NUTRITIONAL REGULATION OF RAS PROTO-ONCOGENE ACTIVITY

RAS原癌基因活性的营养调节

基本信息

项目摘要

The cyclin-dependent kinase inhibitors are a recently characterized class of proteins that regulate progression of the cell cycle and cell number homeostasis. One of these, p21/WAF1/CIP1, can be transcriptionally activated by the tumor suppressor p53 (especially in response to DNA damage) and so links regulation of the cell cycle and tumorigenesis. Transcription of p21 can also be induced independently of p53. The effect of p21 is to cause an arrest of the cell cycle at the G1 phase; depending on the cell type, this G1 arrest can allow time for repair of damaged DNA or lead to apoptotic death. Because of the link between p53 and p21, we examined the expression of p21 in the p53-knockout mouse. We have shown that the early tumor development seen in these animals (chiefly lymphomas with some sarcomas) can be delayed by dietary manipulations such as calorie restriction (CR). Although CR decreased the basal cell cycle rate, it had no effect on expression of p21 in most tissues; however, CR surprisingly decreased the expression of p21 in the livers of both wildtype-p53 and p53-nullizygous mice. Therefore, the action of CR on p21 is independent of the presence of p53 and may be a reflection of the effects of CR, such as decreased levels of the oxidative DNA damage that requires a p21-induced G1 arrest for repair. Another tumor-delaying regimen, administration of dehydroepiandrosterone (DHEA), which specifically decreased lymphoma tumorigenesis in the p53-knockout mice, increased expression of p21 in the liver. The differential effects of CR and DHEA on both p21 expression and tumor spectrum may be related. Studies on other dietary manipulations, together with effect of p53 gene dosage, on the expression of p21 and various proto-oncogenes are in progress. In addition, we are currently developing cultured embryonic fibroblasts from fetuses with or without p53 as a model system for the study of the in vitro effects of various agents on expression of cell cycle regulators. This system will also be used to address the question of how loss of p53 function results in increased genomic instability.
细胞周期蛋白依赖的激酶抑制剂是一类新近被表征的药物 调节细胞周期和细胞数量的蛋白质 动态平衡。其中p21/WAF1/CIP1可以转录 被肿瘤抑制基因P53激活(尤其是对DNA的反应 因此,细胞周期的调节与肿瘤的发生有关。 P21的转录也可以不依赖于p53而被诱导。这个 P21的作用是使细胞周期停滞于G1期; 根据细胞类型的不同,这种G1期停滞可以为修复 破坏DNA或导致细胞凋亡。 由于p53和p21之间的联系,我们检查了该表达 P21基因在p53基因敲除小鼠中的表达。我们已经证明了早期的肿瘤 在这些动物中看到的发展(主要是淋巴瘤和一些 肉瘤)可以通过饮食控制来延迟,例如卡路里 限制(CR)。尽管CR降低了基本细胞周期比率,但它 在大多数组织中不影响p21的表达;然而,令人惊讶的是,CR 降低野生型P53和p21蛋白在肝组织中的表达 P53基因缺失的小鼠。因此,CR对p21的作用是 与P53的存在无关,并可能是效应的反映 例如,氧化DNA损伤水平的降低, 需要p21诱导的G1期停滞才能修复。另一个肿瘤--延缓 方案,给予脱氢表雄酮(DHEA), P53基因敲除特异性降低淋巴瘤的致瘤性 小鼠肝脏中p21的表达增加。差异化效应 CR和DHEA对p21表达和肿瘤谱的影响可能是 相关的。其他饮食调控方法的研究及其作用 P53基因剂量对p21及多种原癌基因表达的影响 正在进行中。此外,我们目前正在开发培养的 以含或不含p53的胎儿胚胎成纤维细胞为模型 不同药剂体外作用的研究系统 细胞周期调节因子的表达。该系统还将用于 解决P53功能丧失如何导致增加的问题 基因组不稳定。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

S N PERKINS其他文献

S N PERKINS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('S N PERKINS', 18)}}的其他基金

NUTRITIONAL REGULATION OF RAS PROTO-ONCOGENE ACTIVITY
RAS原癌基因活性的营养调节
  • 批准号:
    3838276
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
DIETARY MODULATION OF CELL CYCLE REGULATORS
细胞周期调节剂的饮食调节
  • 批准号:
    6160848
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
DIETARY MODULATION OF CELL CYCLE REGULATORS
细胞周期调节剂的饮食调节
  • 批准号:
    6100748
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
NUTRITIONAL REGULATION OF RAS PROTO-ONCOGENE ACTIVITY
RAS原癌基因活性的营养调节
  • 批准号:
    3774731
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
DIETARY MODULATION OF CELL CYCLE REGULATORS
细胞周期调节剂的饮食调节
  • 批准号:
    2468415
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
NUTRITIONAL REGULATION OF RAS PROTO-ONCOGENE ACTIVITY
RAS原癌基因活性的营养调节
  • 批准号:
    3752553
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
NUTRITIONAL REGULATION OF RAS PROTO-ONCOGENE ACTIVITY
RAS原癌基因活性的营养调节
  • 批准号:
    3853374
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Roles of DAMP and autophagy in inflammation-related carcinogenesis and its application to cancer prevention
DAMP和自噬在炎症相关癌发生中的作用及其在癌症预防中的应用
  • 批准号:
    19H03884
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of the novel mechanisms of carcinogenesis induced by the cigarette and development of cancer prevention for carcinogenesis by sidestream smoke
阐明香烟致癌的新机制并开发侧流烟致癌预防方法
  • 批准号:
    15K15241
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Study of obesity-associated carcinogenesis and its application to cancer prevention
肥胖相关癌变研究及其在癌症预防中的应用
  • 批准号:
    26250028
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Epigenetic alteration in inflammation-related carcinogenesis and its application to cancer prevention and therapy
炎症相关癌发生中的表观遗传改变及其在癌症预防和治疗中的应用
  • 批准号:
    25293149
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Basic research for cancer prevention by combinatorial treatment of food constituents based on the signal transduction pathways associated with carcinogenesis
基于与致癌相关的信号转导途径,通过组合治疗食物成分来预防癌症的基础研究
  • 批准号:
    25460809
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Involvement of the melanocortin receptor pathway in pancreatic and colorectal carcinogenesis and its application to cancer prevention
黑皮质素受体途径参与胰腺癌和结直肠癌发生及其在癌症预防中的应用
  • 批准号:
    25290049
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A novel mouse prostate carcinogenesis model for dietary cancer prevention researc
用于饮食癌症预防研究的新型小鼠前列腺癌模型
  • 批准号:
    8450080
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
A novel mouse prostate carcinogenesis model for dietary cancer prevention researc
用于饮食癌症预防研究的新型小鼠前列腺癌模型
  • 批准号:
    8244004
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
Molecular epidemiological elucidation of Japanese, American, and European gastric and colorectal carcinogenesis by integrated analysis of functional RNA and clinical application and cancer prevention
通过功能RNA综合分析及临床应用和癌症预防,分子流行病学阐明日本、美国和欧洲胃癌和结直肠癌的发生
  • 批准号:
    23300366
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Basic research for development of cancer prevention by inhibitory effect of food constituents on the signal transduction pathways associated with carcinogenesis
通过食品成分对致癌相关信号转导途径的抑制作用来预防癌症的基础研究
  • 批准号:
    23790669
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了